Skip to main content
Clinical Trials/NCT04591028
NCT04591028
Withdrawn
Phase 4

Indocyanine Green Lymphangiography as a Tool for Improving Lymphadenectomy in Gastric Cancer

Mayo Clinic1 site in 1 countryJanuary 2022

Overview

Phase
Phase 4
Intervention
Indocyanine green
Conditions
Gastric Cancer
Sponsor
Mayo Clinic
Locations
1
Primary Endpoint
Positive ICG fluorescence lymph nodes
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

This study will be looking at the safety and added benefit of using the Indocyanine green dye (ICG) during surgery.

Registry
clinicaltrials.gov
Start Date
January 2022
End Date
August 10, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Enrique F. Elli

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Patients ≥ 18 and ≤ 75 years of age.
  • Primary gastric adenocarcinoma of any histological subtype confirmed pathologically by endoscopic biopsy.
  • Clinical stage tumor T1-4a (cT1-4a), N -/+, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition.
  • No distant metastasis, no direct invasion of adjacent organs such as pancreas and spleen in preoperative exams.
  • American Society of Anesthesiology score (ASA) class I, II, or III.
  • Written informed consent.

Exclusion Criteria

  • Patients ≤ 18 and ≥ 75 years of age.
  • History of previous upper abdominal surgery (except laparoscopic cholecystectomy).
  • History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection.
  • History of allergy to iodine agents.
  • History of other malignant disease within past five years.
  • Emergency surgery due to complication caused by gastric cancer, such as bleeding obstruction or perforation.
  • Patients intraoperatively/postoperatively confirmed as T4b.
  • Patients intraoperatively confirmed as unable to complete D2 lymph node dissection or R0 dissection.

Arms & Interventions

Intervention

Injection of Indocyamine Green.

Intervention: Indocyanine green

Outcomes

Primary Outcomes

Positive ICG fluorescence lymph nodes

Time Frame: Approximately 30-90 days after surgery

Total number of lymph nodes removed after surgery that are positive for ICG fluorescence

Disease positive lymph nodes

Time Frame: Approximately 30-90 days after surgery

Number of ICG positive lymph nodes that are also positive for disease

Number of lymph nodes removed for each lymphatic station of gastrectomy

Time Frame: Approximately 30-90 days after surgery

Total number of lymph nodes removed for each lymphatic station of gastrectomy with NIR+ICG vs gastrectomy without NIR+ICG

Study Sites (1)

Loading locations...

Similar Trials